S-nitrosoglutathione and hypoxia-inducible factor-1 confer chemoresistance against carbamoylating cytotoxicity of BCNU in rat C6 glioma cells

Annals of the New York Academy of Sciences

Volumn 1042, Issue , 2005, Pages 229-234

  Yang, Ding I ^a   Chen, Shang Der ^b   Yin, Jiu Haw ^c   Hsu, Chung Y ^d,e  

^a TZU CHI UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c TAO YUAN GENERAL HOSPITAL   (Taiwan)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Alkylation; Carbamoylation; Chemoresistance; Chemotherapy; Hypoxia; iNOS; Nitric oxide

Indexed keywords

CARMUSTINE; GLUTATHIONE REDUCTASE; HYPOXIA INDUCIBLE FACTOR 1; INDUCIBLE NITRIC OXIDE SYNTHASE; S NITROSOGLUTATHIONE;

ANIMAL CELL; CARBAMOYLATION; CONFERENCE PAPER; CYTOTOXICITY; DRUG RESISTANCE; ENZYME ACTIVATION; ENZYME INHIBITION; GENE INDUCTION; GLIOMA CELL; NONHUMAN; OXIDATIVE STRESS; PROTEIN INDUCTION; RAT; TRANSACTIVATION;

EID: 22044445724     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1338.025     Document Type: Conference Paper

References (42)

1. KLEIHUES, P. et al. 1995. Histopathology, classification and grading of gliomas. Glia 15:211-221.
2. RAJKUMAR, S.V. et al. 1999. Phase I evaluation of pre-irradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas. Neurosurgery 44: 67-73.
3. PAOLETTI, P. 1984. Therapeutic strategy for central nervous system tumors: present status, criticism and potential. J. Neurosurg. Sci. 28: 51-60.
4. NUTT, C.L. et al. 2000. Differential expression of drug resistance genes and chemosensitivity in glial cell lineages correlate with differential response of oligodendrogliomas and astrocytomas to chemotherapy. Cancer Res. 60: 4812-4818.
5. ROLHION, C. et al. 1999. O(6)-methylguanine-DNA methyltransferase gene (MGMT) expression in human glioblastomas in relation to patient characteristics and p53 accumulation. Int. J. Cancer 84: 416-420.
6. ALI-OSMAN, F. et al. 1990. Glutathione content and glutathione-S- transferase expression in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human malignant astrocytoma cell lines. Cancer Res. 50: 6976-6980.
7. FUJISAWA, H. et al. 1995. Inducible nitric oxide synthase in a human glioblastoma cell line. J. Neurochem. 64: 85-91.
8. KATO, S. et al. 2003. Immunohistochemical expression of inducible nitric oxide synthase (iNOS) in human brain tumors: relationships of iNOS to Superoxide dismutase (SOD) proteins (SOD1 and SOD2), Ki-67 antigen (MIB-1) and p53 protein. Acta Neuropathol. (Berl.) 105: 333-340.
9. HARA, E. et al. 1996. Expression of heme oxygenase and inducible nitric oxide synthase mRNA in human brain tumors. Biochem. Biophys. Res. Commun. 224: 153-158.
10. ELLIE, E. et al. 1995. Differential expression of inducible nitric oxide synthase mRNA in human brain tumours. Neuroreport 7: 294-296.
11. CHIUEH, C.C. & P. RAUHALA. 1999. The redox pathway of S-nitrosoglutathione, glutathione and nitric oxide in cell to neuron communications. Free Radic. Res. 31: 641-650.
12. JU, T.C. et al. 2004. Protective effects of S-nitrosoglutathione against neurotoxicity of 3-nitropropionic acid in rat. Neurosci. Lett. 362: 226-231.
13. RAUHALA, P. et al. 1998. Neuroprotection by S-nitrosoglutathione of brain dopamine neurons from oxidative stress. FASEB J. 12: 165-173.
14. BECKMAN, J.S. et al. 1990. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and Superoxide. Proc. Natl. Acad. Sci. USA 87: 1620-1624.
15. YIN, J.H. et al. 2001. Inducible nitric oxide synthase neutralizes carbamoylating potential of 1,3-bis(2-chloroethyl)-1-nitrosourea in C6 glioma cells. J. Pharmacol. Exp. Ther. 297:308-315.
16. YANG, D.I. et al. 2002. NO-mediated chemoresistance in C6 glioma cells. Ann. N.Y. Acad. Sci. 962: 8-17.
17. YANG, D.I. et al. 2004. Nitric oxide and BCNU chemoresistance in C6 glioma cells: role of S-nitrosoglutathione. Free Radic. Biol. Med. 36: 1317-1328.
18. GORDGE, M.P. et al. 1995. Copper chelation-induced reduction of the biological activity of S-nitrosoglutathione. Br. J. Pharmacol. 114: 1083-1089.
19. AL-SA'DONI, H.H. et al. 1997. Neocuproine, a selective Cu(I) chelator, and the relaxation of rat vascular smooth muscle by S-nitrosothiols. Br. J. Pharmacol. 121: 1047-1050.
20. TEW, K.D. et al. 1985. Carbamoylation of glutathione reductase and changes in cellular and chromosome morphology in a rat cell line resistant to nitrogen mustards but collaterally sensitive to nitrosoureas. Cancer Res. 45: 2326-2333.
21. JOCHHEIM, C.M. & T.A. BAILLIE. 1994. Selective and irreversible inhibition of glutathione reductase in vitro by carbamate thioester conjugates of methyl isocyanate. Biochem. Pharmacol. 47: 1197-1206.
22. VANHOEFER, U. et al. 1997. Carbamoylation of glutathione reductase by N,N-bis(2-chloroethyl)-N-nitrosourea associated with inhibition of multidrug resistance protein (MRP) function. Biochem. Pharmacol. 53: 801-809.
23. RAUHALA, P. et al. 1996. S-nitrosothiols and nitric oxide, but not sodium nitroprusside, protect nigrostriatal dopamine neurons against iron-induced oxidative stress in vivo. Synapse 23: 58-60.
24. WANG, G.L. et al. 1995. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. USA 92: 5510-5514.
25. JIANG, B.H. et al. 1996. Hypoxia-inducible factor I levels vary exponentially over a physiologically relevant range of O2 tension. Am. J. Physiol. 271: C1172-C1180.
26. SEMENZA, G.L. & G.L. WANG. 1992. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 12: 5447-5454.
27. WANG, G.L. & G.L. SEMENZA. 1993. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc. Natl. Acad. Sci. USA 90: 4304-4308.
28. SEMENZA, G.L. et al. 1994. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269: 23757-23763.
29. SEMENZA, G.L. 1998. Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Curr. Opin. Genet. Dev. 8: 588-594.
30. SEMENZA, G.L. 2000. Expression of hypoxia-inducible factor 1: mechanisms and consequences. Biochem. Pharmacol. 59: 47-53.
31. WANG, G.L. & G.L. SEMENZA. 1993. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 82: 3610-3615.
32. KIMURA, H. et al. 2000. Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. Blood 95: 189-197.
33. YANG, D.I. et al. 2004. Carbamoylating chemoresistance induced by cobalt pretreatment in C6 glioma cells: putative roles of hypoxia-inducible factor-1. Br. J. Pharmacol. 141: 988-996.
34. LUND, E.L. et al. 2004. Differential regulation of VEGF, HIF1alpha and angiopoietin-1, -2 and -4 by hypoxia and ionizing radiation in human glioblastoma. Int. J. Cancer 108: 833-838.
35. SONDERGAARD, K.L. et al. 2002. Expression of hypoxia-inducible factor 1alpha in tumours of patients with glioblastoma. Neuropathol. Appl. Neurobiol. 28: 210-217.
36. LIANG, B.C. 1996. Effects of hypoxia on drug resistance phenotype and genotype in human glioma cell lines. J. Neurooncol. 29: 149-155.
37. EBERT, B.L. et al. 1995. Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct cis-acting sequences. J. Biol. Chem. 270: 29083-29089.
38. SHWEIKI, D. et al. 1992. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845.
39. ZAMAN, K. et al. 1999. Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21(waf1/cip1), and erythropoietin. J. Neurosci. 19: 9821-9830.
40. SWAROOP, G.R. et al. 1998. Effects of nitric oxide modulation on tumour blood flow and microvascular permeability in C6 glioma. Neuroreport 9: 2577-2581.
41. FRIEDMAN, H.S. et al. 1998. DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma. J. Clin. Oncol. 16: 3851-3857.
42. SANDERSON, R.J. & D.W. Mosbaugh. 1998. Fidelity and mutational specificity of uracil-initiated base excision DNA repair synthesis in human glioblastoma cell extracts. J. Biol. Chem. 273: 24822-24831.